(Q44403055)

2 December 2017

title

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116). (English)

1 reference

2 December 2017

main subject

phase II clinical trial

0 references

1 reference

A M Oza

1

1 reference

2 December 2017

L Elit

2

1 reference

2 December 2017

K Swenerton

3

1 reference

2 December 2017

W Faught

4

1 reference

2 December 2017

P Ghatage

5

1 reference

2 December 2017

M Carey

6

1 reference

2 December 2017

L McIntosh

7

1 reference

2 December 2017

A Dorr

8

1 reference

2 December 2017

J T Holmlund

9

1 reference

2 December 2017

E Eisenhauer

10

1 reference

2 December 2017

NCIC Clinical Trials Group Study (NCIC IND.116)

11

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

1 reference

2 December 2017

volume

89

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

129-133

1 reference

New drugs in gynecologic oncology

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Predictors of response to subsequent chemotherapy in platinum pretreated ovarian cancer: a multivariate analysis of 704 patients [seecomments]

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Interaction of the protein kinase Raf-1 with 14-3-3 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

The primary structure of MEK, a protein kinase that phosphorylates the ERK gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Activation of human raf transforming genes by deletion of normal amino-terminal coding sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Multinomial phase II cancer trials incorporating response and early progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Application of a new multinomial phase II stopping rule using response and early progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Increased sensitivity to cytosine arabinoside in human leukemia by c-raf-1 antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

Phase I clinical/pharmacokinetic and pharmacodynamic trial of the c-raf-1 antisense oligonucleotide ISIS 5132 (CGP 69846A).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-8258%2802%2900144-0

7 January 2021

10.1016/S0090-8258(02)00144-0

Identifiers

DOI

1 reference

2 December 2017

1 reference